On January 6, JPMorgan reiterated Boston Scientific Corporation (NYSE:BSX) is one of its top pick stocks in the healthcare ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

Market OverviewThe global ostomy devices market is projected to grow at a healthy rate of 4–5% and is expected to reach approximately USD 3.2 billion by 2026. This steady expansion is driven by rising ...

MOUNTAIN VIEW , CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Renaissance Healthcare for Women, led by ...

Fakeeh Health | CEO – Fakeeh University Hospital, stated: “This strategic partnership with Verita Neuro reflects our ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

A woman's decades-long struggle with incontinence was finally solved when doctors discovered a rare condition.

DCGI releases classification of 77 medical devices related to oncology: Gireesh Babu, New Delhi Wednesday, January 7, 2026, 08:00 Hrs [IST] As part of its efforts to regulate the ...

This article was reviewed by Julia Switzer, MD, FACOG. Urinary incontinence is the term for a loss of bladder control. In women, it can present at any age, but it’s most common after pregnancy, ...

Acquisition to expand urology offerings for people living with overactive bladder MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...

Universal Quantum has staked its reputation on the trapped-ion approach, allowing it to scale in the quickest and most ...